Skip to content

Integration of Follow-up by First and Second Line Practitioners by Telemonitoring in Heart Failure.

Integration of Follow-up by First and Second Line Practitioners Facilitated by Telemonitoring Versus Stand-alone Telemonitoring in Patients With Severe Heart Failure

Status
Terminated
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01696890
Acronym
TEMA-HF2
Enrollment
50
Registered
2012-10-01
Start date
2011-10-31
Completion date
2013-12-31
Last updated
2015-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Heart Failure

Keywords

chronic heart failure, telemonitoring, first line practitioners, integrated approach, efficacy

Brief summary

The aim of this study is to evaluate this model of telemonitoring-assisted close supervision and interaction between first and second line health professionals versus a model of telemonitoring without this integrated approach.

Detailed description

The incidence of acute decompensated heart failure is increasing. Patients with severe heart failure are rehospitalised for decompensation several times each year, increasing the cost for health care. In these cases of recurrent decompensation, the medical intervention in hospital is often limited to increasing the dosage of diuretics or vasodilators until the patient reaches a compensated state. After discharge, a readmission can be expected within a few months. A multidisciplinary approach by primary physician, heart failure nurse, rehabilitation team and cardiologist has been shown to decrease rehospitalisation rate and increase quality of life. Very recently, our study group showed that an intense collaboration between first line practitioner and heart failure clinic, facilitated by the use of telemonitoring, can reduce mortality and hospitalisation rate. This study was a RIZIV sponsored trial of 6 months follow-up in patients with chronic heart failure. However, a large randomised multicentre trial investigating the use of telemonitoring in a population of heart failure (NYHA II-III) patients did not find any difference between telemonitoring and usual care (Chaudry et al NEJM 2010). In contradiction with this study, a Cochrane meta-analysis (Ingliss 2010) in more than 5000 patients confirmed our finding with a reduction in mortality and morbidity. The question therefore remains which factors are responsible for success or failure of the use of telemonitoring. Based on our previous experience, the approach of close monitoring by telemonitoring, with first line intervention by the patient's general practitioner (GP) and supervision by the heart failure clinic, might be the critical success factor. Therefore, the aim of this study is to evaluate this model of telemonitoring-assisted close supervision and interaction between first and second line health professionals versus a model of telemonitoring without this integrated approach.

Interventions

DEVICEintegrated follow-up

close interaction between HF clinic and general practitioner in response to telemonitoring alerts. All subjects will be monitored daily for heart rate, blood pressure, and body weight, after which these data are transferred automatically to the general practitioner. This device is custom-made.

DEVICEstandard care

no interaction between HF clinic and general practitioner in response to telemonitoring alerts. General practitioner is responsible for adaptations to therapy according to clinical presentation of the patient.

Sponsors

Jessa Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
60 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* patients hospitalized for decompensation of systolic heart failure * LVEF \< 40% during hospitalization.

Exclusion criteria

* reversible forms of acute heart failure (acute ischemia, myocarditis,..) * heart failure due to severe aortic stenosis * participation in cardiac rehabilitation after discharge * previous or actual residency in a nursing home * creatinine clearance \<15 ml/min * planned dialysis in the next 6 months * planned biventricular pacemaker or cardiac surgery * life expectancy of less than 1 year due to other diseases * severe obstructive pulmonary disease (Gold III) * significant mental or cognitive problems interfering with the daily measurements or intake of medication.

Design outcomes

Primary

MeasureTime frame
number of rehospitalizations6 months
time investment by HF nurses6 months
overall mortality6 months

Secondary

MeasureTime frame
quality of life6 months
appearance of renal failure (glomerular filtration rate (GFR) <60 mL/min/1.73 m2)6 months

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026